Twenty-two years of dengue outbreaks in Bangladesh: epidemiology, clinical spectrum, serotypes, and future disease risks
- PMID: 37434247
- PMCID: PMC10334535
- DOI: 10.1186/s41182-023-00528-6
Twenty-two years of dengue outbreaks in Bangladesh: epidemiology, clinical spectrum, serotypes, and future disease risks
Abstract
Dengue is the most rapidly spreading mosquito-borne disease and has become a major public health threat, particularly for tropical and subtropical countries including Bangladesh. This comprehensive review aims to summarize the overall scenario of dengue, including disease burden, clinical spectrum, seroprevalence, circulating serotypes/genotypes, and spatial distribution since the first recorded outbreak in Bangladesh. Since the first recorded outbreak in 2000, dengue epidemiology has shown the typical epidemic pattern with more frequent and bigger outbreaks and gradual geographic expansion to non-endemic regions in Bangladesh. For instance, highly confined Rohingya refugee camps that provide shelters to nearly 1.2 million forcibly displaced vulnerable Myanmar nationals in Cox's Bazar district confronted a massive outbreak in 2022. Recent major outbreaks are found to be associated with the emergence of serotype DENV-3, which was undetected for a long time. Consequently, changes in serotypes might be attributed to increased severity in clinical manifestation in recent years. The existing weak surveillance and risk management systems are inadequate to deal with impending dengue risks. The healthcare system, particularly at the district level, is not prepared to manage impending large-scale dengue outbreaks in Bangladesh. Our findings would contribute to the development of strategies for dengue control and management in Bangladesh as well as other similar settings elsewhere in the world.
© 2023. The Author(s).
Conflict of interest statement
We declare that there is no conflict of interest.
Figures




Similar articles
-
Increasing Dengue Burden and Severe Dengue Risk in Bangladesh: An Overview.Trop Med Infect Dis. 2023 Jan 3;8(1):32. doi: 10.3390/tropicalmed8010032. Trop Med Infect Dis. 2023. PMID: 36668939 Free PMC article. Review.
-
Dengue in Bangladesh.Int J Infect Dis. 2023 Jun 29:S1201-9712(23)00644-6. doi: 10.1016/j.ijid.2023.06.020. Online ahead of print. Int J Infect Dis. 2023. PMID: 37393040
-
The 2023 Dengue Outbreak in Bangladesh: An Epidemiological Update.Health Sci Rep. 2025 May 26;8(5):e70852. doi: 10.1002/hsr2.70852. eCollection 2025 May. Health Sci Rep. 2025. PMID: 40432700 Free PMC article.
-
Evaluation of community based surveillance in the Rohingya refugee camps in Cox's Bazar, Bangladesh, 2019.PLoS One. 2020 Dec 23;15(12):e0244214. doi: 10.1371/journal.pone.0244214. eCollection 2020. PLoS One. 2020. PMID: 33362236 Free PMC article.
-
Implementation and Delivery of Oral Cholera Vaccination Campaigns in Humanitarian Crisis Settings among Rohingya Myanmar nationals in Cox's Bazar, Bangladesh.Vaccines (Basel). 2023 Apr 14;11(4):843. doi: 10.3390/vaccines11040843. Vaccines (Basel). 2023. PMID: 37112756 Free PMC article. Review.
Cited by
-
Clinical spectrum and risk factors of severe dengue infection: findings from the 2023 dengue outbreak in Bangladesh.BMC Infect Dis. 2025 Apr 7;25(1):469. doi: 10.1186/s12879-025-10792-y. BMC Infect Dis. 2025. PMID: 40189546 Free PMC article.
-
Epidemiological and Geographical Factors Associated with Dengue in Bangladesh: A Multicenter Study of the 2023 Dengue Epidemic.Am J Trop Med Hyg. 2025 Feb 4;112(4):891-897. doi: 10.4269/ajtmh.24-0477. Print 2025 Apr 2. Am J Trop Med Hyg. 2025. PMID: 39903934
-
Rapid human movement and dengue transmission in Bangladesh: a spatial and temporal analysis based on different policy measures of COVID-19 pandemic and Eid festival.Infect Dis Poverty. 2024 Dec 26;13(1):99. doi: 10.1186/s40249-024-01267-4. Infect Dis Poverty. 2024. PMID: 39722072 Free PMC article.
-
Two decades of endemic dengue in Bangladesh (2000-2022): trends, seasonality, and impact of temperature and rainfall patterns on transmission dynamics.J Med Entomol. 2024 Mar 13;61(2):345-353. doi: 10.1093/jme/tjae001. J Med Entomol. 2024. PMID: 38253990 Free PMC article.
-
Efficacy of human interleukin-11 analogs for treating dengue fever-associated thrombocytopenia: a prospective cohort.Eur J Med Res. 2024 Oct 7;29(1):492. doi: 10.1186/s40001-024-02091-0. Eur J Med Res. 2024. PMID: 39375746 Free PMC article.
References
-
- Dengue and severe dengue. [cited 13 Oct 2022]. Available: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue.
-
- Ten threats to global health in 2019. [cited 13 Oct 2022]. Available: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-....
-
- Dengue vaccine safety update. [cited 14 Jun 2023]. Available: https://www.who.int/groups/global-advisory-committee-on-vaccine-safety/t....
-
- Colón-González FJ, Sewe MO, Tompkins AM, Sjödin H, Casallas A, Rocklöv J, et al. Projecting the risk of mosquito-borne diseases in a warmer and more populated world: a multi-model, multi-scenario intercomparison modelling study. Lancet Planet Heal. 2021;5:e404. doi: 10.1016/S2542-5196(21)00132-7. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources